Medication Adherence Monitoring Trial Using Smart Clinical Trial Application and Smart Watch
NCT ID: NCT05452512
Last Updated: 2023-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2022-07-14
2022-12-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Sunlight Exposure and Vitamin D Supplementation on Serum 25-hydroxyvitamin D Levels
NCT03310242
The Use of the 25 (OH) D Saliva Test as a Substitute for the 25 (OH) D Serum Test in Healthy People
NCT04655664
Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D
NCT02460211
Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults
NCT01398202
Vitamin D Supplementation in Warfighters
NCT02954549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Self monitoring arm using smart clinical trial application
The subjects in this arm will take vitamin D for 3 months and keep track of drug administration using smart clinical trial application (self monitoring).
Self monitoring
Self monitoring using smart clinical trial application
Vitamin D
Vitamin D self-administration for 3 months
Active monitoring using smart watch coupled with self monitoring
The subjects in this arm will take vitamin D for 3 months and keep track of drug administration using smart watch and smart clinical trial application (self monitoring).
Self monitoring
Self monitoring using smart clinical trial application
Smart watch assisted monitoring
Smart watch-assisted adherence monitoring
Vitamin D
Vitamin D self-administration for 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self monitoring
Self monitoring using smart clinical trial application
Smart watch assisted monitoring
Smart watch-assisted adherence monitoring
Vitamin D
Vitamin D self-administration for 3 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 25(OH) vitamin D \< 10 ng/mL
* Not taking vitamin D at the screening
* Fully understood the study procedures
Exclusion Criteria
* Clinically significant hypersensitivity reaction to Vitamin D
* History of or current kidney stone
* One of the following findings:
1. Serum calcium level \> upper limit of normal
2. Estimated glomerular filtration rate \< 60 mL/min/1.73m\^2
* Galactose intolerance, Lapp lactase deficiency, Glucose-galactose malabsorption
* Unable to use smart clinical trial application or smart watch
* Expected to take vitamin D from 4 weeks before the first administration and until the last administration
19 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kim Heejin
Research Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heejin Kim, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital Clinical Trial Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital Clinical Trial Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMART-DRUG-101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.